4.6 Article

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977-2008

期刊

JOURNAL OF CROHNS & COLITIS
卷 5, 期 1, 页码 5-13

出版社

OXFORD UNIV PRESS
DOI: 10.1016/j.crohns.2010.08.004

关键词

UC; CD; Elderly; Age at diagnosis; Incidence; Disease course

向作者/读者索取更多资源

Background and aims: Limited data are available on the incidence and disease course of IBD in the elderly population. Our aim was to analyze the incidence and disease course of IBD according to the age at diagnosis in the population-based Veszprem province database, which included incident patients diagnosed between January 1, 1977 and December 31, 2008. Methods: Data of 1420 incident patients were analyzed (UC: 914, age at diagnosis: 38.9 SD15.9 years; CD: 506, age at diagnosis: 31.5 SD13.8 years). Both hospital and outpatient records were collected and comprehensively reviewed. Results: 106 (11.6%) of UC patients and 21(4.2%) of CD patients were diagnosed with >60 years of age. In UC, the incidence increased from 1.09 to 10.8/10(5) in the elderly, while CD increased to 3.04/10(5) in 2002-2007. In CD, colonic location (elderly: 61.9% vs. pediatric: 24.3%, p=0.001, and adults: 36.8%, p=0.02) and stenosing disease (elderly: 42.9% vs. pediatric: 14.9%, p=0.005, and adults: 19.5%, p=0.01) were more frequent in the elderly. A change in disease behavior was absent in the elderly, while in pediatric and adult CD population it was 20.3% (p=0.037), 19.8% (p=0.036) after 5 years. In UC, extensive disease was more frequent in pediatric patients compared to the elderly (p=0.003, OR: 2.73, 95%CI: 1.38-5.41). In addition, pediatric (57.3%, p<0.001, OR: 6.58; 95%CI: 3.22-12.9) and adult (39.8%, p<0.001, OR: 3.24; 95%CI: 1.91-5.49) patients required more often systemic steroids during follow-up compared to the elderly (17%). Proximal extension at 10 years was 11.6%, but time to extension was not different according to the age at onset. Conclusions: Elderly patients represent an increasing proportion of the IBD population. Stenosing and colon-only disease were characteristic for elderly CD patients, while the disease course in UC was milder. (C) 2010 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Long-term Colectomy Rates of Ulcerative Colitis over 40 Years of Different Therapeutic Eras-Results from a Western Hungarian Population-based Inception Cohort Between 1977 and 2020

Panu Wetwittayakhlang, Lorant Gonczi, Laszlo Lakatos, Zsuzsanna Kurti, Petra Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter L. Lakatos

Summary: This study aimed to assess the colectomy rates of ulcerative colitis (UC) patients in Veszprem Province, Hungary over 40 years. The results showed no significant differences in colectomy rates among different therapeutic eras, despite increasing use of immunomodulators and biologic therapies.

JOURNAL OF CROHNS & COLITIS (2023)

Article Biochemistry & Molecular Biology

Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats

David a. Karadi, Anna Rita Galambos, Peter P. Lakatos, Joost Apenberg, Sarah K. Abbood, Mihaly Balogh, Kornel Kiraly, Pal Riba, Nariman Essmat, Edina Szucs, Sandor Benyhe, Zoltan V. Varga, Eva Szoko, Tamas Tabi, Mahmoud Al-Khrasani

Summary: The study investigates the antiallodynic effect of telmisartan and losartan, two AT1 blockers, in combination with morphine for neuropathic pain management. The combination therapy shows promising results in improving pain and delaying morphine tolerance development. Further studies are needed to analyze the effect of each component in the combination therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Health Care Sciences & Services

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary

M. Mercedesz Angyal, Peter L. Lakatos, Balazs Jenei, Valentin Brodszky, Fanni Rencz

Summary: This study conducted a survey among 312 adult patients with celiac disease in Hungary to assess their health-related quality of life. The results showed that strict adherence to a gluten-free diet may lead to significant health improvements, and age, gender, symptom severity, and comorbidities can affect patients' assessments of their own health.

QUALITY OF LIFE RESEARCH (2023)

Review Gastroenterology & Hepatology

Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials

Mohammad Shehab, Fatema Alrashed, Afrah Alkazemi, Peter L. Lakatos, Talat Bessissow

Summary: The aim of this study was to estimate the risk of major adverse cardiovascular events (MACE) in adult patients with inflammatory bowel disease (IBD) treated with biologic therapies and small molecules. The results showed that the risk of MACE was not higher than placebo in patients receiving biologic or small molecule therapies during induction and maintenance phases of randomized controlled trials (RCTs).

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Medicine, General & Internal

The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer

Panu Wetwittayakhlang, Paraskevi Tselekouni, Reem Al-Jabri, Talat Bessissow, Peter L. Lakatos

Summary: Patients with inflammatory bowel disease (IBD) have an increased risk of cancer due to chronic inflammation and long-term use of immunosuppressive therapy. The prevalence of cancer in IBD patients is increasing, requiring concern about the impact of IBD therapy on cancer risk and survival. Managing IBD patients with cancer is challenging as guidelines are based on expert consensus and evidence is limited.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Gastroenterology & Hepatology

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N. Bernstein, Gilaad G. Kaplan, Dana Duricova, Dan Greenberg, Hans O. Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valerie E. H. Pittet, Vito Annese, K. T. Park, Konstantinos H. Katsanos, Marte L. Hoivik, Zeljko Krznaric, Maria Chaparro, Edward V. Loftus, Peter L. Lakatos, Javier P. Gisbert, Willem Bemelman, Bjorn Moum, Richard B. Gearry, Michael D. Kappelman, Ailsa Hart, Marieke J. Pierik, Jane M. Andrews, Siew C. Ng, Renata D'Inca, Pia Munkholm

Summary: The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide due to the steady increase in prevalence, the chronic nature of the diseases, expensive treatments, intensive monitoring, and their impact on productivity. This Commission urges evaluation of cost increases against improved disease management and the need for data interoperability and big data approaches to assess effectiveness and cost-effectiveness. International collaborations and novel care models should be sought to enhance education and training for clinicians, patients, and policy makers.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Declining Trends of Reoperations and Disease Behaviour Progression in Crohn's Disease over Different Therapeutic Eras-A Prospective, Population-Based Study from Western Hungary between 1977-2020, Data from the Veszprem Cohort

Lorant Gonczi, Laszlo Lakatos, Petra A. Golovics, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Alex Al Khoury, Peter L. Lakatos

Summary: This study aimed to analyze disease progression and surgery rates in population-based cohort over different therapeutic eras. The study found that the probability of disease progression from inflammatory to stenosing or penetrating phenotype significantly decreased and the probability of first resective surgery also decreased. Overall, the rates of surgery and disease progression decreased over time.

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Burden of perianal disease and perianal surgery in Crohn's disease over different therapeutic eras - a population-based study from western Hungary between 1977-2020, data from the Veszprem county cohort

L. Gonczi, L. Lakatos, P. A. Golovics, T. Pandur, G. David, Z. Erdelyi, I. Szita, P. L. Lakatos

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Long-term disease progression and resective surgery rates in Crohn's disease over different therapeutic eras - a population-based study from western Hungary between 1977-2020, data from the Veszprem county cohort

L. Gonczi, L. Lakatos, P. A. Golovics, T. Pandur, G. David, Z. Erdelyi, I. Szita, P. L. Lakatos

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Frequent Early Nocebo Complaints but Maintained Clinical Efficacy, Biomarker and Therapeutic drug levels following mandatory Biosimilar Switch in Patients with Inflammatory Bowel disease: Preliminary data from a Prospective Observational Cohort Study

P. Wetwittayakhlang, K. Karkout, P. Tselekouni, R. Aljabri, T. Bessissow, W. Afif, G. Wild, A. Bitton, P. L. Lakatos

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

The Burden of Colorectal Cancer in Patients with Ulcerative Colitis - Incidence and Risk factors from a Population-based Inception Cohort from Veszprem county, Western Hungary, from 1977-2020

P. Wetwittayakhlang, P. Golovics, L. Gonczi, A. Khoury, Z. Kurti, T. Pandur, G. David, Z. Erdelyi, I. Szita, L. Lakatos, P. L. Lakatos

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Time Trends of Environmental and Socioeconomical Factors in Patients with Inflammatory Bowel Disease over 40-year of Different Therapeutic Eras; results from a Population-based Cohort from Western Hungarian between 1977-2020, The Hygiene hypothesis revisited

P. Wetwittayakhlang, L. Gonczi, L. Lakatos, P. Golovics, T. Pandur, G. David, Z. Erdelyi, I. Szita, P. L. Lakatos

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras - Results from a Western Hungarian Population-based Inception Cohort between 1977-2020

P. L. Lakatos, L. Gonczi, L. Lakatos, P. A. Golovics, T. Pandur, G. David, Z. Erdelyi, I. Szita

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study

T. Resal, P. Bacsur, R. Bor, A. Balint, K. Katsanos, G. Michalopoylos, D. G. Ribaldone, M. Attauabi, Z. Mirabella, H. Yanai, C. Bezzio, F. Castiglione, A. Bar-Gil Shitrit, D. Pugliese, P. L. Lakatos, E. Savarino, M. Lukas, M. Franko, E. Chashkova, P. Molander, S. Nancey, L. Bannon, Z. Krznaric, R. Filip, T. Szamosi, K. Kastylova, P. Sarlos, H. Ami-Barak, A. Rispo, J. Limdi, A. Kagramanova, Z. Szepes, K. Farkas, T. Molnar

JOURNAL OF CROHNS & COLITIS (2023)

Meeting Abstract Gastroenterology & Hepatology

Endoscopic and clinical outcomes of upadacitinib in patients with moderate to severe Crohn's disease by baseline disease severity

B. Siegmund, K. Patel, E. A. Torres, P. L. Lakatos, J. Seidelin, M. Fleisher, S. Ford, V. Remple, A. P. Lacerda, S. Anyanwu, A. Garrison, J. Panes

JOURNAL OF CROHNS & COLITIS (2023)

暂无数据